Assyro AI
Back to firms
FEI 30077720562 published 483s

Revance Therapeutics, Inc.

United States· latest record Jul 15, 2022

At a glance

Overview

Published 483s2
Locations1
Establishment types1
Record span2021–2022

Revance Therapeutics, Inc. is an FDA-registered establishment (FEI 3007772056) based in United States. The FDA OII FOIA reading room has published 2 Form 483 records for this firm between 2021 and 2022. Recorded establishment type: Active Pharmaceutical Ingredient & Finished Dosage Manufacturer.

Form 483 activity by yearFirst flagged Jul 02, 2021 · most recent 4 years ago
OII FOIA reading room

Form 483 records2

Registered & inspected sites

Locations

Loading map…
United StatesHQ2 records